Category: Uncategorized

Prior to ASCO, Breaking Data asked 30 oncologists to rate each abstract in terms of their level of interest. The chart depicts pre-ASCO oncologist interest in the data…

During ASCO, Breaking Data asked 30 oncologists to select which solid tumor abstracts had the most potential to impact their practice. The chart depicts the number of oncologists…

During ASCO, Breaking Data asked 30 oncologists to select which checkpoint inhibitor offers the best risk-benefit ratio in aNSCLC. The chart depicts the number of oncologists…